Discover a study that has revealed that pemafibrate is more effective than omega-3 fatty acid ethyl in reducing fatty liver ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

A low-carb diet plan for people with type-2 diabetes helped half of participants in a study lower their average blood-sugar readings to non-diabetic levels in just three months – results in a similar ...

Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM: San Francisco, US Tuesday, May 27, 2025, 11:00 Hrs [IST ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

The study targets adults in China with overweight or obesity accompanied metabolic dysfunction-associated fatty liver disease (MAFLD ... of mazdutide versus semaglutide in Chinese adults with ...

The study targets adults in China with overweight or obesity accompanied metabolic dysfunction-associated fatty liver disease (MAFLD ... of mazdutide versus semaglutide in Chinese adults with ...